![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2062646893/2065058613/gr1.gif)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
CHAMPION Clinical Trial: Substantial reduction in 30-day readmissions in Medicare-eligible patients - Background and Rationale for Implantable Hemodynamic Monitoring - Hemodynamic Monitoring for Heart Failure Patients
![CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so. - ppt download CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so. - ppt download](https://slideplayer.com/16381394/95/images/slide_1.jpg)
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so. - ppt download
![Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram](https://www.researchgate.net/publication/350461679/figure/fig1/AS:1012276240850954@1618356871831/Long-term-results-from-the-CHAMPION-trial-Effect-of-pulmonary-artery-pressureguided_Q320.jpg)
Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram
![BostonSci Cardiology on X: "CHAMPION-AF is Boston Scientific's 5th #LAAC randomized controlled trial vs. pharmacotherapy, adding to nearly 20 years of clinical leadership. Learn more about how this trial seeks to expand BostonSci Cardiology on X: "CHAMPION-AF is Boston Scientific's 5th #LAAC randomized controlled trial vs. pharmacotherapy, adding to nearly 20 years of clinical leadership. Learn more about how this trial seeks to expand](https://pbs.twimg.com/media/E5N0adsVEAAhp4h.jpg)
BostonSci Cardiology on X: "CHAMPION-AF is Boston Scientific's 5th #LAAC randomized controlled trial vs. pharmacotherapy, adding to nearly 20 years of clinical leadership. Learn more about how this trial seeks to expand
![Cumulative heart-failure-related hospitalisations during the entire... | Download Scientific Diagram Cumulative heart-failure-related hospitalisations during the entire... | Download Scientific Diagram](https://www.researchgate.net/publication/337365248/figure/fig2/AS:827001397067785@1574183906644/Cumulative-heart-failure-related-hospitalisations-during-the-entire-period-of-randomised.jpg)
Cumulative heart-failure-related hospitalisations during the entire... | Download Scientific Diagram
![Benefits of Pulmonary Artery Pressure Monitoring in Patients with NYHA Class III Heart Failure and Chronic Kidney Disease: Results from the CHAMPION Trial - Journal of Cardiac Failure Benefits of Pulmonary Artery Pressure Monitoring in Patients with NYHA Class III Heart Failure and Chronic Kidney Disease: Results from the CHAMPION Trial - Journal of Cardiac Failure](https://onlinejcf.com/cms/attachment/2016897991/2037374848/fx1.jpg)
Benefits of Pulmonary Artery Pressure Monitoring in Patients with NYHA Class III Heart Failure and Chronic Kidney Disease: Results from the CHAMPION Trial - Journal of Cardiac Failure
![Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in “Real-World” Clinical Practice - ScienceDirect Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in “Real-World” Clinical Practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717359788-fx1.jpg)
Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in “Real-World” Clinical Practice - ScienceDirect
Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejectio
![Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram](https://www.researchgate.net/publication/350461679/figure/fig1/AS:1012276240850954@1618356871831/Long-term-results-from-the-CHAMPION-trial-Effect-of-pulmonary-artery-pressureguided.png)
Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/1d41ebf5-9657-435f-9dff-165db3d18406/gr2_lrg.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation](https://bridgetoinnovation.org/wp-content/uploads/2021/03/Implementation-Champions-infographic-pdf.jpg)
Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation
![John P Erwin III MD FACC on X: "#CardioMEMS #CHAMPION trial - reduced hospitalizations for #HeartFailure ; Quality of Life also improved https://t.co/LbUHLNhIUF" / X John P Erwin III MD FACC on X: "#CardioMEMS #CHAMPION trial - reduced hospitalizations for #HeartFailure ; Quality of Life also improved https://t.co/LbUHLNhIUF" / X](https://pbs.twimg.com/media/CnvFJcsUsAAlJGv.png)
John P Erwin III MD FACC on X: "#CardioMEMS #CHAMPION trial - reduced hospitalizations for #HeartFailure ; Quality of Life also improved https://t.co/LbUHLNhIUF" / X
![Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI | tctmd.com Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2012-03/111786.png?itok=M5FBk3C7)
Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI | tctmd.com
![BostonSci Cardiology on X: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men BostonSci Cardiology on X: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men](https://pbs.twimg.com/media/E86mrDrXEAQ24Hp.jpg)
BostonSci Cardiology on X: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men
![Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/b618415d-93e7-4e59-a88c-0ddf922788c7/gr1_lrg.jpg)
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet
Champion Clinical Trial: Managing to Target PA Pressures - Background and Rationale for Implantable Hemodynamic Monitoring - Hemodynamic Monitoring for Heart Failure Patients
![Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/0571e47e-bf75-4e84-a0dd-2f17877cca31/gr3.jpg)
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet
![TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics – The CHAMPION PHOENIX Trial | tctmd.com TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics – The CHAMPION PHOENIX Trial | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2015-10/131812.png?itok=oi848V1J)